FDA Inspection 1163117 — Ira J. Goodman, MD
The FDA completed an inspection of Ira J. Goodman, MD on February 17, 2022 in Orlando, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 17, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Orlando, FL (United States)
Additional Details
Clinical Investigator (CI)